Protagonist Therapeutics director Williams sells $1.48 million in shares

Protagonist Therapeutics director Williams sold $1.48 million worth of company shares in the United States on June 15, 2023, in a transaction that reflects normal executive trading activity. The sale occurred through open market transactions as part of the director's personal portfolio management. The biotechnology company, which specializes in developing novel therapies for gastrointestinal and liver diseases, has seen its stock perform moderately over the past year. Director sales of company shares are common events that don't necessarily indicate negative sentiment about the company's prospects, as executives often diversify their holdings for personal financial planning purposes. Protagonist Therapeutics has been working on several promising drug candidates, including their lead compound for inflammatory bowel disease, while continuing to advance its clinical pipeline in the challenging biotech investment environment.